Literature DB >> 16120784

5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology.

Elena Kvachnina1, Guoquan Liu, Alexander Dityatev, Ute Renner, Aline Dumuis, Diethelm W Richter, Galina Dityateva, Melitta Schachner, Tatyana A Voyno-Yasenetskaya, Evgeni G Ponimaskin.   

Abstract

The neurotransmitter serotonin (5-HT) plays an important role in the regulation of multiple events in the CNS. We demonstrated recently a coupling between the 5-HT4 receptor and the heterotrimeric G13-protein resulting in RhoA-dependent neurite retraction and cell rounding (Ponimaskin et al., 2002). In the present study, we identified G12 as an additional G-protein that can be activated by another member of serotonin receptors, the 5-HT7 receptor. Expression of 5-HT7 receptor induced constitutive and agonist-dependent activation of a serum response element-mediated gene transcription through G12-mediated activation of small GTPases. In NIH3T3 cells, activation of the 5-HT7 receptor induced filopodia formation via a Cdc42-mediated pathway correlating with RhoA-dependent cell rounding. In mouse hippocampal neurons, activation of the endogenous 5-HT7 receptors significantly increased neurite length, whereas stimulation of 5-HT4 receptors led to a decrease in the length and number of neurites. These data demonstrate distinct roles for 5-HT7R/G12 and 5-HT4R/G13 signaling pathways in neurite outgrowth and retraction, suggesting that serotonin plays a prominent role in regulating the neuronal cytoarchitecture in addition to its classical role as neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120784      PMCID: PMC6725246          DOI: 10.1523/JNEUROSCI.1790-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

1.  The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo.

Authors:  M L Ruchhoeft; S Ohnuma; L McNeill; C E Holt; W A Harris
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Differential expression of the small GTP-binding proteins RhoA, RhoB, Cdc42u and Cdc42b in developing rat neocortex.

Authors:  C Olenik; K Aktories; D K Meyer
Journal:  Brain Res Mol Brain Res       Date:  1999-06-18

3.  Different roles for RhoA during neurite initiation, elongation, and regeneration in PC12 cells.

Authors:  A Sebök; N Nusser; B Debreceni; Z Guo; M F Santos; J Szeberenyi; G Tigyi
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

Review 4.  A review of central 5-HT receptors and their function.

Authors:  N M Barnes; T Sharp
Journal:  Neuropharmacology       Date:  1999-08       Impact factor: 5.250

5.  Effects of serotonin on neurite outgrowth from thalamic neurons in vitro.

Authors:  V Lieske; C A Bennett-Clarke; R W Rhoades
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

6.  Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters.

Authors:  M J Duncan; J Short; D L Wheeler
Journal:  Brain Res       Date:  1999-05-22       Impact factor: 3.252

7.  Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.

Authors:  O Kranenburg; M Poland; F P van Horck; D Drechsel; A Hall; W H Moolenaar
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

8.  Dentate granule cell function after neonatal treatment with parachloroamphetamine or 5,7-dihydroxytryptamine.

Authors:  J H Haring; W Yan
Journal:  Brain Res Dev Brain Res       Date:  1999-05-14

9.  Serotonin and the 5-HT(2B) receptor in the development of enteric neurons.

Authors:  E Fiorica-Howells; L Maroteaux; M D Gershon
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

10.  Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo.

Authors:  Y Kawano; Y Fukata; N Oshiro; M Amano; T Nakamura; M Ito; F Matsumura; M Inagaki; K Kaibuchi
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  70 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 3.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

4.  Expression of 5-HT7 receptor mRNA in the hamster brain: effect of aging and association with calbindin-D28K expression.

Authors:  Marilyn J Duncan; Kathleen M Franklin
Journal:  Brain Res       Date:  2007-01-20       Impact factor: 3.252

Review 5.  Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases.

Authors:  Evgeni Ponimaskin; Tatyana Voyno-Yasenetskaya; Diethelm W Richter; Melitta Schachner; Alexander Dityatev
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 6.  The serotonin 5-HT7 receptors: two decades of research.

Authors:  Evelien Gellynck; Karen Heyninck; Kjetil W Andressen; Guy Haegeman; Finn Olav Levy; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  Exp Brain Res       Date:  2013-09-17       Impact factor: 1.972

7.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

8.  Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.

Authors:  Jessica A Knight; Carol Smith; Nicole Toohey; Michael T Klein; Milt Teitler
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

9.  Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.

Authors:  Bianca De Filippis; Paola Nativio; Alessia Fabbri; Laura Ricceri; Walter Adriani; Enza Lacivita; Marcello Leopoldo; Francesca Passarelli; Andrea Fuso; Giovanni Laviola
Journal:  Neuropsychopharmacology       Date:  2014-05-09       Impact factor: 7.853

10.  Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders.

Authors:  Minako Tajiri; Atsuko Hayata-Takano; Kaoru Seiriki; Katsuya Ogata; Keisuke Hazama; Norihito Shintani; Akemichi Baba; Hitoshi Hashimoto
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.